VXRT trade ideas
VXRT Liquidity Stock AlertLIQUIDITY STOCK ALERT
$VXRT - Vaxart, Inc. - Common Stock
Initial Price: $7.65
Potential Price: $17.49
Potential Gains: 129%
Stop Loss Limit: $7.27
Looking at the Consolidation for VXRT over the course of the last 5 months, we're starting to see a reversal in the stock. VXRT hit our Liquidity Stock Scanner and the move has been confirmed on our Breakout Stock Scanner on the 1-Hour EMA Crossover. We expect this to work through the following Levels of Resistance over the course of the next month:
Level 1: $8.49
Level 2: $9.43
Level 3: #12.49
We're aiming for Level 2 of Resistance ($9.49) for our Minimum Price Target which would provide a 23% ROI in our 1-Month Time Frame. #Breakout #Stocks #Trading #Investing #Alerts #StockMarket #Daily #News #Today
Follow for more trade alerts and information & egister your account for Instant Alerts by clicking the link in our signature.
$VXRT Vaxart Inc Long Above the 100MAVaxart, Inc. operates as a clinical-stage biotechnology company, which engages in the development of oral recombinant vaccines. Its products include Influenza, Norovirus and Respiratory Syncytial Virus. The company was founded in 2004 and is headquartered in South San Francisco, CA.
short interest 29%
Symmetrical triangle breakout direction unclear on $VXRTWeekly channel is up ---> bullish
Strong tests of resistance fail to follow-through ---> bearish
Price volume higher on bullish bars and decreases on bearish bars ---> bullish
Price action can be interpreted as distribution or accumulation ---> neutral
Increased institutional interest ---> bullish
Dilution ---> bearish (probably short-term)
CONCLUSION: could go either way, triangle breakout will be decisive
Set alerts to signal potential entry.
VXRT (Only Pill Vaccine for COVID 19) PT $19.67Today went almost 20% down after having continuous 7 days upward movement. It will keep a downward trend without news since the support at $7.30 has been broken. The next support is at $6.58 and reversal will be there. There are a lot of catalysts on the way but the whole market is going downward.
NHP result, PR of the conference, Flu Vaccination result, OWS, Funding, and so on.
I am not an expert in stock analysis. I am just sharing what I feel about this stock. Please comment below what do you think about it.
$VXRT Vaxart, Inc Alert set for break above 50maVaxart, Inc. operates as a clinical-stage biotechnology company, which engages in the development of oral recombinant vaccines. Its products include Influenza, Norovirus and Respiratory Syncytial Virus. The company was founded in 2004 and is headquartered in South San Francisco, CA.